BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 22136512)

  • 1. HLA alleles and drug hypersensitivity reactions.
    Profaizer T; Eckels D
    Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
    Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
    J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
    Ko TM; Chen YT
    Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HLA-B*5701 and abacavir hypersensitivity reaction].
    Servonnet A; Leclercq E; Delacour H; Ceppa F
    Pathol Biol (Paris); 2010 Dec; 58(6):e95-100. PubMed ID: 19243901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
    Lucas A; Nolan D; Mallal S
    J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping for severe drug hypersensitivity.
    Karlin E; Phillips E
    Curr Allergy Asthma Rep; 2014 Mar; 14(3):418. PubMed ID: 24429903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
    Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
    Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic information derived from analysis of HLA alleles.
    Gatanaga H; Honda H; Oka S
    Pharmacogenomics; 2008 Feb; 9(2):207-14. PubMed ID: 18370849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA and Delayed Drug-Induced Hypersensitivity.
    Sousa-Pinto B; Correia C; Gomes L; Gil-Mata S; Araújo L; Correia O; Delgado L
    Int Arch Allergy Immunol; 2016; 170(3):163-79. PubMed ID: 27576480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
    Yeo SI
    Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
    Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
    Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of drug hypersensitivity.
    Phillips EJ; Mallal SA
    Pharmacogenomics; 2010 Jul; 11(7):973-87. PubMed ID: 20602616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase.
    Chui CK; Brumme ZL; Brumme CJ; Yip B; Phillips EJ; Montaner JS; Harrigan PR
    Clin Infect Dis; 2007 Jun; 44(11):1503-8. PubMed ID: 17479950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients.
    Moragas M; Belloso WH; Baquedano MS; Gutierrez MI; Bissio E; Larriba JM; Fay F; Aulicino P; Gurevich JM; Yaunguzian MF; Maldonado AC; Falistocco C; Sen L; Mangano A
    Tissue Antigens; 2015 Jul; 86(1):28-31. PubMed ID: 25922880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.